This issue of the Communicable Disease Threats Report (CDTR) covers the period 15-21 January 2023 and includes updates on COVID-19, diphtheriae, influenza, Mpox and Cholera.
This issue of the CDTR covers the period 18-24 December 2022 and includes updates on chikungunya, cholera, COVID-19, dengue, C. diphtheriae, Ebola, influenza A(H5N1), Influenza A(H9N2), mass gathering monitoring, Mpox, swine influenza.
This guidance document includes an updated summary of diagnostic PCR and serology together with detailed information on isolation, culture, identification and epidemiological typing of B. pertussis to help users choose the best methods within the local technical and financial provisions.
Hepatitis A cases in 2021 were at their lowest levels since EU-level hepatitis A surveillance began in 2007, while five other food and waterborne diseases are rising towards pre-pandemic levels. The information is revealed in the Annual Epidemiological Report 2021, of which six chapters are published today by ECDC.
For 2021, 6 534 confirmed cases of STEC infection were reported by 30 EU/EEA countries (Table 1). Twenty-seven countries reported at least two confirmed cases, and three countries reported no cases. The EU/EEA notification rate was 2.2 cases per 100 000 population, representing a 37.5% increase compared with the previous year.
This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring and surveillance activities carried out in 2021 in 27 MSs, the United Kingdom (Northern Ireland) and nine non-MSs.
This issue of the CDTR covers the period 27 November – 3 December 2022 and includes updates on COVID-19, Ebola, diphtheria, respiratory syncytial virus, seasonal influenza, monkeypox, mass gathering monitoring at the FIFA World Cup 2022 Qatar, Chikungunya, dengue, Shigella sonnei, poliomyelitis, meningitis, cholera.
You may already know about PrEP - the pill one takes to reduce the risk of acquiring HIV. But did you know there is also PEP - the post-exposure prophylaxis - that is used after one may have been exposed to the HIV virus.